Clinical chemistry is integral to laboratory testing and is often referred to as a core lab discipline. Reports from Kalorama Information pay special attention to trends in greater healthcare, clinical laboratory investment and automation technology to determine how established in vitro diagnostics (IVD) markets such as clinical chemistry will be affected. This IVD market segment is also routinely analyzed in emerging regions such as China, India, the Middle East, and other Asian countries.
Many in the clinical and manufacturing community have their eyes on the Physician Office Laboratory (POL) as an outlet both to improve patient compliance and outcomes and to open new market opportunities. Studies are emerging on the clinical outcomes and cost-benefit of nearer-the-patient testing, but little certain is known about POLs as a distribution channel […]
May 1, 2007
The current population of India is 1.065 billion, and with a growth rate of 1.7%, India will surpass China to become the world’s largest country around 2030. For diagnostic manufacturers, this enormous market is just now being recognized as a high-growth area as the pace of economic growth in India accelerates and modern laboratory practices […]
December 1, 2006